EMA All Set To Oversee Use Of COVID-19 Treatments, Vaccines In Clinical Practice
Three Observational Research Projects Were Signed In Three Months
Executive Summary
The European Medicines Agency has finalized infrastructure to monitor the safety and effectiveness of COVID-19 medicines and vaccines when they are used in day-to-day clinical practice following marketing authorization.
You may also be interested in...
EU Mandates Monthly Safety Summaries For Approved COVID-19 Vaccines
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.
EU Guide Supports Strong Observational Research For COVID‐19
An EU guideline on the methodological aspects of pharmacoepidemiology has been updated to promote collaboration by researchers on high-quality, multi-centre observational studies in the context of COVID-19.
EMA Commissions Research On Real-World Monitoring Of COVID-19 Vaccines
The European Medicines Agency is taking steps to establish infrastructure for monitoring COVID-19 vaccines whenever they reach the European market.